Skip to main content

and
  1. Article

    Open Access

    A cost-effectiveness analysis of the combination of serplulimab with chemotherapy for advanced esophageal squamous cell carcinoma: insights from the ASTRUM-007 trial

    Combined serplulimab and chemotherapy demonstrated improved clinical survival outcomes in patients with advanced esophageal squamous cell carcinoma (ESCC) and PD-L1 combined positive scores (CPS) ≥ 1. The pres...

    Jiahui Li, Chaoqun Xu, Suyun Yuan in Cost Effectiveness and Resource Allocation (2024)